A Study of Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia
Clinical trial NCT05736965 · RECRUITING
Trial details
- NCT number
- NCT05736965
- Sponsor
- Shanghai Tong Ren Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-20
- Primary completion
- 2025-03-30
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.